JP2008519035A5 - - Google Patents

Download PDF

Info

Publication number
JP2008519035A5
JP2008519035A5 JP2007540055A JP2007540055A JP2008519035A5 JP 2008519035 A5 JP2008519035 A5 JP 2008519035A5 JP 2007540055 A JP2007540055 A JP 2007540055A JP 2007540055 A JP2007540055 A JP 2007540055A JP 2008519035 A5 JP2008519035 A5 JP 2008519035A5
Authority
JP
Japan
Prior art keywords
group
hydrogen atom
hydroxy
carbonyl
lower alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007540055A
Other languages
English (en)
Japanese (ja)
Other versions
JP5198067B2 (ja
JP2008519035A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/039911 external-priority patent/WO2006052710A1/en
Publication of JP2008519035A publication Critical patent/JP2008519035A/ja
Publication of JP2008519035A5 publication Critical patent/JP2008519035A5/ja
Application granted granted Critical
Publication of JP5198067B2 publication Critical patent/JP5198067B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2007540055A 2004-11-05 2005-11-03 4−ヒドロキシベンゾモルファン Expired - Lifetime JP5198067B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US62534804P 2004-11-05 2004-11-05
US60/625,348 2004-11-05
PCT/US2005/039911 WO2006052710A1 (en) 2004-11-05 2005-11-03 4-hydroxybenzomorphans

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012256445A Division JP6058981B2 (ja) 2004-11-05 2012-11-22 4−ヒドロキシベンゾモルファン

Publications (3)

Publication Number Publication Date
JP2008519035A JP2008519035A (ja) 2008-06-05
JP2008519035A5 true JP2008519035A5 (cg-RX-API-DMAC10.html) 2008-11-13
JP5198067B2 JP5198067B2 (ja) 2013-05-15

Family

ID=36128632

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2007540055A Expired - Lifetime JP5198067B2 (ja) 2004-11-05 2005-11-03 4−ヒドロキシベンゾモルファン
JP2012256445A Expired - Lifetime JP6058981B2 (ja) 2004-11-05 2012-11-22 4−ヒドロキシベンゾモルファン
JP2015159733A Pending JP2016020364A (ja) 2004-11-05 2015-08-12 4−ヒドロキシベンゾモルファン

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2012256445A Expired - Lifetime JP6058981B2 (ja) 2004-11-05 2012-11-22 4−ヒドロキシベンゾモルファン
JP2015159733A Pending JP2016020364A (ja) 2004-11-05 2015-08-12 4−ヒドロキシベンゾモルファン

Country Status (20)

Country Link
US (7) US7262298B2 (cg-RX-API-DMAC10.html)
EP (2) EP2251330B1 (cg-RX-API-DMAC10.html)
JP (3) JP5198067B2 (cg-RX-API-DMAC10.html)
KR (1) KR101115841B1 (cg-RX-API-DMAC10.html)
CN (1) CN101090891B (cg-RX-API-DMAC10.html)
AT (1) ATE557006T1 (cg-RX-API-DMAC10.html)
AU (1) AU2005304950B2 (cg-RX-API-DMAC10.html)
BR (1) BRPI0517091B8 (cg-RX-API-DMAC10.html)
CA (1) CA2587074C (cg-RX-API-DMAC10.html)
CY (1) CY1112946T1 (cg-RX-API-DMAC10.html)
DK (1) DK2251330T3 (cg-RX-API-DMAC10.html)
ES (1) ES2387737T3 (cg-RX-API-DMAC10.html)
IL (1) IL182983A (cg-RX-API-DMAC10.html)
MX (1) MX2007005389A (cg-RX-API-DMAC10.html)
NO (1) NO340204B1 (cg-RX-API-DMAC10.html)
PL (1) PL2251330T3 (cg-RX-API-DMAC10.html)
PT (1) PT2251330E (cg-RX-API-DMAC10.html)
RU (2) RU2415131C2 (cg-RX-API-DMAC10.html)
SI (1) SI2251330T1 (cg-RX-API-DMAC10.html)
WO (1) WO2006052710A1 (cg-RX-API-DMAC10.html)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE292625T1 (de) * 2000-10-31 2005-04-15 Rensselaer Polytech Inst 8-substituierte 2,6-methano-3-benzazocine und 3- substituierte morphinane als opioidrezeptorbindende agenzien
US7262298B2 (en) * 2004-11-05 2007-08-28 Rensselaer Polytechnic Institute 4-hydroxybenzomorphans
AU2006272773B2 (en) 2005-07-21 2012-03-08 Rensselaer Polytechnic Institute 8-carboxamido-substituted-2 , 6-methano-3-benzazocines and 3 - carboxamido- substituted morphanes as opioid receptor binding agents
ATE493416T1 (de) 2007-05-04 2011-01-15 Mallinckrodt Inc Verbessertes verfahren zur herstellung von 6- alpha-hydroxy-n-alkylierten opiaten
JP2010533719A (ja) 2007-07-17 2010-10-28 マリンクロッド・インコーポレイテッド 還元的アミノ化によるn−アルキル化オピエートの調製
WO2009023567A1 (en) 2007-08-09 2009-02-19 Rensselaer Polytechnic Institute Quaternary opioid carboxamides
CA2738628C (en) 2008-09-30 2017-07-04 Mallinckrodt Inc. Processes for the selective amination of ketomorphinans
US8946419B2 (en) 2009-02-23 2015-02-03 Mallinckrodt Llc (+)-6-hydroxy-morphinan or (+)-6-amino-morphinan derivatives
WO2010107457A1 (en) * 2009-03-19 2010-09-23 Alkermes, Inc. Morphinan derivatives with high oral bioavailability
WO2010118274A1 (en) * 2009-04-09 2010-10-14 Mallinckrodt Inc. Preparation of 6-keto, 3-alkoxy morphinans
US8471023B2 (en) 2009-06-11 2013-06-25 Mallinckrodt Llc Reductive amination of 6-keto normorphinans by catalytic hydrogen transfer
CA2764915C (en) 2009-06-11 2017-07-11 Mallinckrodt Llc Preparation of 6-alpha-amino n-substituted morphinans by catalytic hydrogen transfer
HUE043963T2 (hu) * 2009-12-04 2019-09-30 Alkermes Pharma Ireland Ltd Morfinán származékok gyógyszer-túladagolás kezelésére
WO2011119605A2 (en) 2010-03-22 2011-09-29 Rensselaer Polytechnic Institute Carboxamide biosiosteres of opiates
WO2011137086A1 (en) * 2010-04-29 2011-11-03 Mallinckrodt Llc Preparation of saturated ketone morphinan compounds having low metal content
WO2012005795A1 (en) 2010-07-08 2012-01-12 Alkermes, Inc. Process for the synthesis of substituted morphinans
EP2608670B1 (en) 2010-08-23 2018-10-31 Alkermes Pharma Ireland Limited Methods for treating antipsychotic-induced weight gain
US9029543B2 (en) 2011-04-05 2015-05-12 Alkermes, Inc. Process for the synthesis of quaternary amine compounds
ES2698408T3 (es) 2011-06-09 2019-02-04 SpecGx LLC Aminación reductora de 6-ceto morfinanos por transferencia de hidrógeno catalítico
CA2840643C (en) 2011-06-29 2017-11-21 Alkermes, Inc. Peripherally acting opioid compounds
KR20140063763A (ko) 2011-09-08 2014-05-27 말린크로트 엘엘씨 중간체를 단리하지 않는 알칼로이드의 제조 방법
SMT201800664T1 (it) 2011-12-15 2019-01-11 Alkermes Pharma Ireland Ltd Samidorphan (alks 33) in combinazione con buprenorfina per il trattamento di disturbi depressivi
US9211293B2 (en) 2011-12-15 2015-12-15 Alkermes Pharma Ireland Limited Opioid agonist antagonist combinations
ES2770978T3 (es) 2013-05-24 2020-07-06 Alkermes Pharma Ireland Ltd Análogos de morfanos y morfinanos y métodos de uso
US9656961B2 (en) 2013-05-24 2017-05-23 Alkermes Pharma Ireland Limited Methods for treating depressive symptoms
KR20190120212A (ko) * 2017-03-02 2019-10-23 가부시키가이샤산와카가쿠켄큐쇼 알코올 사용 장해의 치료약
CN107089948B (zh) * 2017-04-28 2020-07-17 云南大学 吗吩衍生物及其制备方法和应用
CN111978252A (zh) * 2019-05-21 2020-11-24 复旦大学 手性苯并吗吩烷类衍生物及其制备方法和在药学上的应用
TW202140009A (zh) * 2020-02-13 2021-11-01 大陸商上海翰森生物醫藥科技有限公司 3-甲醯胺基-4-羥基納曲酮氘代衍生物、其製備方法及其在醫藥上的應用
CN111205151B (zh) * 2020-02-29 2021-03-05 深圳市祥根生物科技有限公司 一种布洛芬杂质i的环保制备方法
WO2022101444A1 (en) 2020-11-12 2022-05-19 Alkermes Pharma Ireland Limited Immediate release multilayer tablet
CN114621238B (zh) * 2020-12-10 2026-02-03 鲁南制药集团股份有限公司 一种制备纳呋拉啡的方法
KR102663533B1 (ko) * 2021-11-09 2024-05-08 백미선 레이저 치료기기용 온냉각장치

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3957793A (en) * 1974-09-20 1976-05-18 Sterling Drug Inc. Hydroxyiminobenzazocines
US4032529A (en) * 1974-09-20 1977-06-28 Sterling Drug Inc. Aminomethanobenzazocine intermediates
SU635868A3 (ru) * 1974-11-12 1978-11-30 Бристол Мейерз Компани (Фирма) Способ получени морфиновых производных или их солей
US4205171A (en) * 1976-01-12 1980-05-27 Sterling Drug Inc. Aminomethanobenzazocines and nitromethanobenzazocines
US4373139A (en) * 1979-04-30 1983-02-08 Motorola, Inc. Detectors
US4649200A (en) * 1986-05-08 1987-03-10 Regents Of The University Of Minnesota Substituted pyrroles with opioid receptor activity
EP0632041A1 (en) 1993-07-01 1995-01-04 Katholieke Universiteit Nijmegen New morphine derivatives having improved analgesic and narcotic properties
HUP9900974A3 (en) 1996-01-10 2000-09-28 Smithkline Beecham Spa Heterocycle-condensed morphinoid derivatives, process for the preparation thereof, their use and pharmaceutical compositions containing them
ATE292625T1 (de) * 2000-10-31 2005-04-15 Rensselaer Polytech Inst 8-substituierte 2,6-methano-3-benzazocine und 3- substituierte morphinane als opioidrezeptorbindende agenzien
WO2004007449A1 (en) * 2002-07-16 2004-01-22 Rensselaer Polytechnic Institute Process for conversion of phenols to carboxamides via the succinimide esters
US7262298B2 (en) * 2004-11-05 2007-08-28 Rensselaer Polytechnic Institute 4-hydroxybenzomorphans

Similar Documents

Publication Publication Date Title
JP6058981B2 (ja) 4−ヒドロキシベンゾモルファン
US9890129B2 (en) Aminoalkylbenzothiazepine derivatives and uses thereof
US6784187B2 (en) 8-carboxamido-2,6-methano-3-benzazocines
JP2002542245A (ja) 置換イミダゾール、それらの製造および使用
JP2016535784A5 (cg-RX-API-DMAC10.html)
JP2016512823A5 (cg-RX-API-DMAC10.html)
WO2007049532A1 (ja) アミノジヒドロチアジン誘導体
JP2000516593A (ja) 糖尿病及び肥満症の治療に用いられる選択的β▲下3▼作動物質としての置換スルホンアミド
US11932631B2 (en) Process for preparing aficamten
TW201111374A (en) Compounds which selectively modulate the CB2 receptor
EP2158201A2 (fr) Derives de 7 -alkynyl-1.8-naphthyrid0nes, leur preparation et leur application en therapeutique
EP2485804A1 (en) Substituted phenylcarbamoyl alkylamino arene compounds and n,n'-bis-arylurea compounds
TW201121962A (en) Compounds which selectively modulate the CB2 receptor
CN113278012A (zh) 用作激酶抑制剂的化合物及其应用
JP3839813B2 (ja) カンプトテシン誘導体の調製に有用な化合物
WO1995023147A1 (en) Heterocyclic compound
CN108129377B (zh) 一种取代吲哚在中性条件下直接合成取代2-吲哚酮的方法
CN112105355A (zh) Abhd12抑制剂及其制造和使用方法
CN108329236B (zh) 一种恩杂鲁胺中间体的制备方法
CN101314604A (zh) 7α-取代苯基-6α,14α-endo-亚乙(烯)基-四氢蒂巴因衍生物或其盐类,制备方法和用途
JP2024544556A (ja) Drak2阻害剤およびその製造方法と使用
JP2025537627A (ja) セレン含有複素環式化合物およびその使用
WO2006030931A1 (ja) N-置換-n-(4-ピペリジニル)アミド誘導体
WO2025152964A1 (en) Novel compounds as glucocorticoid receptor modulators and uses thereof
JPS60112762A (ja) α−アリ−ル−α−ピリジル脂肪酸誘導体およびその製法